The targeted therapy to HGF/c-Met signal pathway is a new highlight in the treatments of lung cancer.In this review, we will discuss the dysregulation of HGF/c-Met signal pathway in lung cancer and the new progress for the targeted drugs to this pathway. The gene discussed is MET; the disease is lung cancer.